AstraZeneca PLC (AZN)
90.29
-1.22
(-1.33%)
USD |
NASDAQ |
Dec 11, 16:00
89.77
-0.52
(-0.58%)
Pre-Market: 09:10
AstraZeneca Cash from Investing (Quarterly): -2.088B for Sept. 30, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| GSK Plc | -2.150B |
| Amgen, Inc. | -414.00M |
| Regeneron Pharmaceuticals, Inc. | -402.90M |
| Autolus Therapeutics Plc | 35.49M |
| Moderna, Inc. | 700.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 5.202B |
| Cash from Financing (Quarterly) | -2.058B |
| Free Cash Flow | 9.870B |
| Free Cash Flow Per Share (Quarterly) | 1.116 |
| Free Cash Flow to Equity (Quarterly) | 3.691B |
| Free Cash Flow to Firm (Quarterly) | 3.821B |
| Free Cash Flow Yield | 3.50% |